deferiprone has been researched along with Brain Hemorrhage in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Deferiprone (L1) was discontinued as it was suspected to be the offending agent and prompt broad-spectrum antibiotic therapy was initiated after which the patient improved." | 1.34 | Febrile neutropenia and hemorrhagic stroke in a thalassemia major patient. ( Inati, A; Koussa, S; Sheikh-Taha, M; Taher, A, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sheikh-Taha, M | 1 |
| Koussa, S | 1 |
| Inati, A | 1 |
| Taher, A | 1 |
1 other study available for deferiprone and Brain Hemorrhage
| Article | Year |
|---|---|
Febrile neutropenia and hemorrhagic stroke in a thalassemia major patient.
Topics: Adult; Agranulocytosis; beta-Thalassemia; Blood Transfusion; Deferiprone; Female; Humans; Intracrani | 2007 |